{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:49:07Z","timestamp":1789753747025,"version":"4.0.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T00:00:00Z","timestamp":1748131200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T00:00:00Z","timestamp":1748131200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Oral squamous cell carcinoma (OSCC) is a prevalent form of cancer globally. This disease is characterized by its complex genetic underpinnings, involving the intricate regulation of multiple genes. Genetic factors influence cellular processes such as growth, differentiation, and apoptosis of oral mucosal cells, thereby promoting or inhibiting tumor formation and progression. Furthermore, environmental factors\u2014including smoking, alcohol consumption, and human papillomavirus (HPV) infection\u2014can significantly increase the risk of developing OSCC. These external influences can impact the disease in several ways. Delayed clinical detection and the absence of specific biomarkers, coupled with expensive treatment alternatives, contribute to poor prognoses among OSCC patients. Thus, identifying OSCC biomarkers has become imperative. This study investigates publicly accessible sequencing data of oral mucosal tissues from four distinct datasets\u2014GSE23558, GSE30784, GSE36090, and GSE51010\u2014archived in the Gene Expression Omnibus (GEO) database. By analyzing these datasets, which encompass a range of genetic profiles and experimental conditions, the study seeks to uncover critical biomarkers and molecular pathways involved in the early stages of OSCC development. The primary objective is to identify pivotal genes linked to the onset of OSCC. The findings provide preliminary evidence for therapeutic targets in OSCC and may serve as a robust foundation for subsequent biological research endeavors.<\/jats:p>","DOI":"10.1038\/s41598-025-01364-w","type":"journal-article","created":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T05:13:49Z","timestamp":1748150029000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Transcriptional reprogramming in oral squamous cell carcinoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Xianyang","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,25]]},"reference":[{"key":"1364_CR1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.semcancer.2019.09.011","volume":"61","author":"A Chai","year":"2020","unstructured":"Chai, A., Lim, K. P. & Cheong, S. C. Translational genomics and recent advances in oral squamous cell carcinoma[J]. Semin Cancer Biol. 61, 71\u201383 (2020).","journal-title":"Semin Cancer Biol."},{"issue":"9","key":"1364_CR2","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/jop.12733","volume":"47","author":"PJ Thomson","year":"2018","unstructured":"Thomson, P. J. Perspectives on oral squamous cell carcinoma prevention-proliferation, position, progression and prediction[J]. J. Oral Pathol. Med. 47 (9), 803\u2013807 (2018).","journal-title":"J. Oral Pathol. Med."},{"key":"1364_CR3","doi-asserted-by":"crossref","unstructured":"Pekarek, L. et al. Emerging histological and serological biomarkers in oral squamous cell carcinoma: applications in diagnosis, prognosis evaluation and personalized therapeutics (Review)[J]. Oncol. Rep., 50(6). (2023).","DOI":"10.3892\/or.2023.8650"},{"issue":"7","key":"1364_CR4","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1002\/ijc.33352","volume":"148","author":"Z Ling","year":"2021","unstructured":"Ling, Z., Cheng, B. & Tao, X. Epithelial-to-mesenchymal transition in oral squamous cell carcinoma: challenges and opportunities[J]. Int. J. Cancer. 148 (7), 1548\u20131561 (2021).","journal-title":"Int. J. Cancer"},{"issue":"4","key":"1364_CR5","doi-asserted-by":"publisher","first-page":"3721","DOI":"10.3390\/curroncol30040283","volume":"30","author":"M Badwelan","year":"2023","unstructured":"Badwelan, M. et al. Oral squamous cell carcinoma and concomitant primary tumors, what do we know?? A review of the Literature[J]. Curr. Oncol. 30 (4), 3721\u20133734 (2023).","journal-title":"Curr. Oncol."},{"issue":"12","key":"1364_CR6","doi-asserted-by":"publisher","first-page":"100988","DOI":"10.1016\/j.disamonth.2020.100988","volume":"66","author":"G Sarode","year":"2020","unstructured":"Sarode, G. et al. Epidemiologic aspects of oral cancer[J]. Dis. Mon. 66 (12), 100988 (2020).","journal-title":"Dis. Mon"},{"issue":"10","key":"1364_CR7","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1002\/cac2.12194","volume":"41","author":"X Meng","year":"2021","unstructured":"Meng, X. et al. The role of non-coding RNAs in drug resistance of oral squamous cell carcinoma and therapeutic potential[J]. Cancer Commun. (Lond). 41 (10), 981\u20131006 (2021).","journal-title":"Cancer Commun. (Lond)"},{"issue":"3","key":"1364_CR8","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1080\/21505594.2014.999570","volume":"6","author":"CU Hubbers","year":"2015","unstructured":"Hubbers, C. U. & Akgul, B. HPV and cancer of the oral cavity[J]. Virulence 6 (3), 244\u2013248 (2015).","journal-title":"Virulence"},{"issue":"1","key":"1364_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.bjoms.2022.11.001","volume":"61","author":"CY Chieng","year":"2023","unstructured":"Chieng, C. Y., Dalal, A. & Ilankovan, V. Occupational exposure and risk of oral and oropharyngeal squamous cell carcinoma: systematic review and 25-year retrospective cohort study of patients[J]. Br. J. Oral Maxillofac. Surg. 61 (1), 39\u201348 (2023).","journal-title":"Br. J. Oral Maxillofac. Surg."},{"issue":"11","key":"1364_CR10","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1016\/j.annonc.2020.07.011","volume":"31","author":"JP Machiels","year":"2020","unstructured":"Machiels, J. P. et al. Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up[J]. Ann. Oncol. 31 (11), 1462\u20131475 (2020).","journal-title":"Ann. Oncol."},{"issue":"9","key":"1364_CR11","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1038\/s41416-020-01253-1","volume":"124","author":"M Oliva","year":"2021","unstructured":"Oliva, M. et al. Transitions in oral and gut Microbiome of HPV\u2009+\u2009oropharyngeal squamous cell carcinoma following definitive chemoradiotherapy (ROMA LA-OPSCC study) [J]. Br. J. Cancer. 124 (9), 1543\u20131551 (2021).","journal-title":"Br. J. Cancer"},{"key":"1364_CR12","doi-asserted-by":"publisher","first-page":"4293","DOI":"10.2147\/IJN.S377816","volume":"17","author":"M Cao","year":"2022","unstructured":"Cao, M. et al. Personalized targeted therapeutic strategies against oral squamous cell carcinoma. An Evidence-Based review of Literature[J]. Int. J. Nanomed. 17, 4293\u20134306 (2022).","journal-title":"Int. J. Nanomed."},{"issue":"2","key":"1364_CR13","doi-asserted-by":"publisher","first-page":"408","DOI":"10.2214\/AJR.15.14713","volume":"206","author":"YS Choi","year":"2016","unstructured":"Choi, Y. S. et al. Human papillomavirus and epidermal growth factor receptor in oral cavity and oropharyngeal squamous cell carcinoma: correlation with dynamic Contrast-Enhanced MRI Parameters[J]. AJR Am. J. Roentgenol. 206 (2), 408\u2013413 (2016).","journal-title":"AJR Am. J. Roentgenol."},{"issue":"9","key":"1364_CR14","first-page":"11884","volume":"8","author":"C Rivera","year":"2015","unstructured":"Rivera, C. Essentials of oral cancer[J]. Int. J. Clin. Exp. Pathol. 8 (9), 11884\u201311894 (2015).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"1364_CR15","doi-asserted-by":"publisher","first-page":"103760","DOI":"10.1016\/j.pdpdt.2023.103760","volume":"44","author":"J Fu","year":"2023","unstructured":"Fu, J. et al. Improving oral squamous cell carcinoma diagnosis and treatment with fluorescence molecular imaging[J]. Photodiagnosis Photodyn Ther. 44, 103760 (2023).","journal-title":"Photodiagnosis Photodyn Ther."},{"issue":"D1","key":"1364_CR16","doi-asserted-by":"publisher","first-page":"D138","DOI":"10.1093\/nar\/gkad965","volume":"52","author":"E Clough","year":"2024","unstructured":"Clough, E. et al. NCBI GEO: archive for gene expression and epigenomics data sets: 23-year update[J]. Nucleic Acids Res. 52 (D1), D138\u2013D144 (2024).","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"1364_CR17","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","volume":"28","author":"JT Leek","year":"2012","unstructured":"Leek, J. T. et al. The Sva package for removing batch effects and other unwanted variation in high-throughput experiments[J]. Bioinformatics 28 (6), 882\u2013883 (2012).","journal-title":"Bioinformatics"},{"issue":"7","key":"1364_CR18","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies[J]. Nucleic Acids Res. 43 (7), e47 (2015).","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"1364_CR19","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu, T. et al. ClusterProfiler 4.0: A universal enrichment tool for interpreting omics data[J]. Innov. (Camb). 2 (3), 100141 (2021).","journal-title":"Innov. (Camb)"},{"key":"1364_CR20","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder, P. & Horvath, S. WGCNA: an R package for weighted correlation network analysis[J]. BMC Bioinform. 9, 559 (2008).","journal-title":"BMC Bioinform."},{"issue":"4","key":"1364_CR21","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/bioinformatics\/btr709","volume":"28","author":"R Kolde","year":"2012","unstructured":"Kolde, R. et al. Robust rank aggregation for gene list integration and meta-analysis[J]. Bioinformatics 28 (4), 573\u2013580 (2012).","journal-title":"Bioinformatics"},{"issue":"1","key":"1364_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10059-013-2249-1","volume":"35","author":"YM Kim","year":"2013","unstructured":"Kim, Y. M. & Kim, D. H. dRAGging amino acid-mTORC1 signaling by SH3BP4[J]. Mol. Cells. 35 (1), 1\u20136 (2013).","journal-title":"Mol. Cells"},{"issue":"8","key":"1364_CR23","doi-asserted-by":"publisher","first-page":"e367","DOI":"10.1038\/emm.2017.115","volume":"49","author":"KH Kim","year":"2017","unstructured":"Kim, K. H., Lee, T. R. & Cho, E. G. SH3BP4, a novel pigmentation gene, is inversely regulated by miR-125b and MITF[J]. Exp. Mol. Med. 49 (8), e367 (2017).","journal-title":"Exp. Mol. Med."},{"issue":"6","key":"1364_CR24","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.molcel.2012.04.007","volume":"46","author":"YM Kim","year":"2012","unstructured":"Kim, Y. M. et al. SH3BP4 is a negative regulator of amino acid-Rag GTPase-mTORC1 signaling[J]. Mol. Cell. 46 (6), 833\u2013846 (2012).","journal-title":"Mol. Cell."},{"issue":"8","key":"1364_CR25","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.devcel.2021.03.009","volume":"56","author":"CJ Burckhardt","year":"2021","unstructured":"Burckhardt, C. J., Minna, J. D. & Danuser, G. SH3BP4 promotes neuropilin-1 and alpha5-integrin endocytosis and is inhibited by Akt[J]. Dev. Cell. 56 (8), 1164\u20131181 (2021).","journal-title":"Dev. Cell."},{"issue":"9","key":"1364_CR26","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1016\/j.celrep.2019.01.110","volume":"26","author":"P Antas","year":"2019","unstructured":"Antas, P. et al. SH3BP4 regulates intestinal stem cells and tumorigenesis by modulating beta-Catenin nuclear Localization[J]. Cell. Rep. 26 (9), 2266\u20132273 (2019).","journal-title":"Cell. Rep."},{"key":"1364_CR27","doi-asserted-by":"publisher","first-page":"1050741","DOI":"10.3389\/fonc.2022.1050741","volume":"12","author":"V Chat","year":"2022","unstructured":"Chat, V. et al. A genome-wide association study of germline variation and melanoma prognosis[J]. Front. Oncol. 12, 1050741 (2022).","journal-title":"Front. Oncol."},{"issue":"1","key":"1364_CR28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s40164-022-00339-1","volume":"11","author":"Z Dong","year":"2022","unstructured":"Dong, Z. & Zhou, H. Pan-cancer landscape of aberrant DNA methylation across childhood cancers: molecular characteristics and clinical relevance[J]. Exp. Hematol. Oncol. 11 (1), 89 (2022).","journal-title":"Exp. Hematol. Oncol."},{"issue":"11","key":"1364_CR29","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1016\/j.pec.2018.05.024","volume":"101","author":"A Stoilkova-Hartmann","year":"2018","unstructured":"Stoilkova-Hartmann, A. et al. COPD patient education and support - Achieving patient-centredness[J]. Patient Educ. Couns. 101 (11), 2031\u20132036 (2018).","journal-title":"Patient Educ. Couns."},{"key":"1364_CR30","doi-asserted-by":"publisher","first-page":"1280977","DOI":"10.3389\/fonc.2023.1280977","volume":"13","author":"F Siegel","year":"2023","unstructured":"Siegel, F. et al. GIPC1 regulates MACC1-driven metastasis[J]. Front. Oncol. 13, 1280977 (2023).","journal-title":"Front. Oncol."},{"issue":"11","key":"1364_CR31","doi-asserted-by":"publisher","first-page":"5294","DOI":"10.3390\/cimb44110360","volume":"44","author":"MA Dymova","year":"2022","unstructured":"Dymova, M. A. et al. MicroRNA and mRNA expression changes in glioblastoma cells cultivated under conditions of neurosphere Formation[J]. Curr. Issues Mol. Biol. 44 (11), 5294\u20135311 (2022).","journal-title":"Curr. Issues Mol. Biol."},{"issue":"1","key":"1364_CR32","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1038\/s41467-017-01762-3","volume":"8","author":"R Yonehara","year":"2017","unstructured":"Yonehara, R. et al. Structural basis for the assembly of the Ragulator-Rag GTPase complex[J]. Nat. Commun. 8 (1), 1625 (2017).","journal-title":"Nat. Commun."},{"issue":"6462","key":"1364_CR33","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1126\/science.aax3939","volume":"366","author":"M Anandapadamanaban","year":"2019","unstructured":"Anandapadamanaban, M. et al. Architecture of human rag GTPase heterodimers and their complex with mTORC1[J]. Science 366 (6462), 203\u2013210 (2019).","journal-title":"Science"},{"issue":"2","key":"1364_CR34","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.cell.2010.02.024","volume":"141","author":"Y Sancak","year":"2010","unstructured":"Sancak, Y. et al. Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids[J]. Cell 141 (2), 290\u2013303 (2010).","journal-title":"Cell"},{"issue":"4","key":"1364_CR35","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.molcel.2013.09.016","volume":"52","author":"ZY Tsun","year":"2013","unstructured":"Tsun, Z. Y. et al. The folliculin tumor suppressor is a GAP for the RagC\/D GTPases that signal amino acid levels to mTORC1[J]. Mol. Cell. 52 (4), 495\u2013505 (2013).","journal-title":"Mol. Cell."},{"issue":"8","key":"1364_CR36","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s00439-016-1685-3","volume":"135","author":"PA Long","year":"2016","unstructured":"Long, P. A. et al. De Novo RRAGC mutation activates mTORC1 signaling in syndromic fetal dilated cardiomyopathy[J]. Hum. Genet. 135 (8), 909\u2013917 (2016).","journal-title":"Hum. Genet."},{"issue":"7826","key":"1364_CR37","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41586-020-2444-0","volume":"585","author":"G Napolitano","year":"2020","unstructured":"Napolitano, G. et al. A substrate-specific mTORC1 pathway underlies Birt-Hogg-Dube syndrome[J]. Nature 585 (7826), 597\u2013602 (2020).","journal-title":"Nature"},{"issue":"7948","key":"1364_CR38","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s41586-022-05652-7","volume":"614","author":"Z Cui","year":"2023","unstructured":"Cui, Z. et al. Structure of the lysosomal mTORC1-TFEB-Rag-Ragulator megacomplex[J]. Nature 614 (7948), 572\u2013579 (2023).","journal-title":"Nature"},{"issue":"2","key":"1364_CR39","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/ng.3473","volume":"48","author":"J Okosun","year":"2016","unstructured":"Okosun, J. et al. Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma[J]. Nat. Genet. 48 (2), 183\u2013188 (2016).","journal-title":"Nat. Genet."},{"issue":"21","key":"1364_CR40","doi-asserted-by":"publisher","first-page":"5383","DOI":"10.1158\/1078-0432.CCR-16-0609","volume":"22","author":"ZX Ying","year":"2016","unstructured":"Ying, Z. X. et al. Recurrent mutations in the MTOR regulator RRAGC in follicular Lymphoma[J]. Clin. Cancer Res. 22 (21), 5383\u20135393 (2016).","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"1364_CR41","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/s42255-019-0098-8","volume":"1","author":"A Ortega-Molina","year":"2019","unstructured":"Ortega-Molina, A. et al. Oncogenic rag GTPase signaling enhances B cell activation and drives follicular lymphoma sensitive to Pharmacological Inhibition of mTOR[J]. Nat. Metab. 1 (8), 775\u2013789 (2019).","journal-title":"Nat. Metab."},{"issue":"3","key":"1364_CR42","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1080\/15548627.2023.2259735","volume":"20","author":"L Xia","year":"2024","unstructured":"Xia, L. et al. Direct regulation of FNIP1 and FNIP2 by MEF2 sustains MTORC1 activation and tumor progression in pancreatic cancer[J]. Autophagy 20 (3), 505\u2013524 (2024).","journal-title":"Autophagy"},{"issue":"34","key":"1364_CR43","doi-asserted-by":"publisher","first-page":"6804","DOI":"10.1021\/bi300778t","volume":"51","author":"MR Jackson","year":"2012","unstructured":"Jackson, M. R., Melideo, S. L. & Jorns, M. S. Human sulfide:quinone oxidoreductase catalyzes the first step in hydrogen sulfide metabolism and produces a sulfane sulfur metabolite[J]. Biochemistry 51 (34), 6804\u20136815 (2012).","journal-title":"Biochemistry"},{"issue":"45","key":"1364_CR44","doi-asserted-by":"publisher","first-page":"30901","DOI":"10.1074\/jbc.M114.602664","volume":"289","author":"M Libiad","year":"2014","unstructured":"Libiad, M. et al. Organization of the human mitochondrial hydrogen sulfide oxidation pathway[J]. J. Biol. Chem. 289 (45), 30901\u201330910 (2014).","journal-title":"J. Biol. Chem."},{"issue":"6","key":"1364_CR45","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1021\/acschembio.8b00258","volume":"13","author":"AP Landry","year":"2018","unstructured":"Landry, A. P., Ballou, D. P. & Banerjee, R. Modulation of catalytic promiscuity during hydrogen sulfide Oxidation[J]. ACS Chem. Biol. 13 (6), 1651\u20131658 (2018).","journal-title":"ACS Chem. Biol."},{"issue":"3","key":"1364_CR46","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s00441-014-1983-9","volume":"358","author":"M Ackermann","year":"2014","unstructured":"Ackermann, M. et al. The vertebrate homologue of sulfide-quinone reductase in mammalian mitochondria[J]. Cell. Tissue Res. 358 (3), 779\u2013792 (2014).","journal-title":"Cell. Tissue Res."},{"key":"1364_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2011.10.044","volume":"199","author":"M Ackermann","year":"2011","unstructured":"Ackermann, M. et al. The vertebrate homolog of sulfide-quinone reductase is expressed in mitochondria of neuronal tissues[J]. Neuroscience 199, 1\u201312 (2011).","journal-title":"Neuroscience"},{"issue":"9","key":"1364_CR48","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1007\/s00198-018-4575-9","volume":"29","author":"X Cai","year":"2018","unstructured":"Cai, X. et al. Genetic susceptibility of postmenopausal osteoporosis on sulfide Quinone reductase-like gene[J]. Osteoporos. Int. 29 (9), 2041\u20132047 (2018).","journal-title":"Osteoporos. Int."},{"issue":"8","key":"1364_CR49","doi-asserted-by":"publisher","first-page":"e135285","DOI":"10.1371\/journal.pone.0135285","volume":"10","author":"HS Jin","year":"2015","unstructured":"Jin, H. S. et al. Association of the I264T variant in the sulfide Quinone reductase-like (SQRDL) gene with osteoporosis in Korean postmenopausal women[J]. PLoS One. 10 (8), e135285 (2015).","journal-title":"PLoS One"},{"issue":"61","key":"1364_CR50","doi-asserted-by":"publisher","first-page":"104508","DOI":"10.18632\/oncotarget.22356","volume":"8","author":"S Zhang","year":"2017","unstructured":"Zhang, S. et al. hsa-miR-29c-3p regulates biological function of colorectal cancer by targeting SPARC[J]. Oncotarget 8 (61), 104508\u2013104524 (2017).","journal-title":"Oncotarget"},{"key":"1364_CR51","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.sleep.2023.12.026","volume":"114","author":"J Gui","year":"2024","unstructured":"Gui, J. et al. Identification of novel proteins for sleep apnea by integrating genome-wide association data and human brain proteomes[J]. Sleep. Med. 114, 92\u201399 (2024).","journal-title":"Sleep. Med."},{"issue":"3","key":"1364_CR52","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1080\/21505594.2014.999570","volume":"6","author":"CU H\u00fcbbers","year":"2015","unstructured":"H\u00fcbbers, C. U. & Akg\u00fcl, B. HPV and cancer of the oral cavity. Virulence 6 (3), 244\u2013248. https:\/\/doi.org\/10.1080\/21505594.2014.999570 (2015).","journal-title":"Virulence"},{"issue":"3","key":"1364_CR53","doi-asserted-by":"publisher","first-page":"e130","DOI":"10.1002\/imt2.130","volume":"2","author":"L Liu","year":"2023","unstructured":"Liu, L. et al. HPVTIMER: A Shiny web application for tumor immune Estimation in human papillomavirus-associated cancers. Imeta 2 (3), e130. https:\/\/doi.org\/10.1002\/imt2.130 (2023). PMID: 38867938; PMCID: PMC10989930.","journal-title":"Imeta"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01364-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01364-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01364-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T06:02:10Z","timestamp":1748152930000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01364-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,25]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1364"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-01364-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4943366\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,25]]},"assertion":[{"value":"20 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18210"}}